Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom. [electronic resource]
Producer: 20070927Description: 631-8 p. digitalISSN:- 0954-691X
- Adult
- Antiviral Agents -- administration & dosage
- Cost-Benefit Analysis
- Drug Administration Schedule
- Drug Costs -- statistics & numerical data
- Health Care Costs -- statistics & numerical data
- Hepatitis B e Antigens -- blood
- Hepatitis B, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Lamivudine -- administration & dosage
- Markov Chains
- Models, Econometric
- Polyethylene Glycols -- administration & dosage
- Quality of Life
- Recombinant Proteins
- Sensitivity and Specificity
- United Kingdom
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.